SUBSCRIBE
SUBSCRIBE
News   Business

Amazon Biotech Announces Letter Of Intent From A Major Medical Center To Fund Clinical Trials

December 1, 2005 | 
1 min read

Amazon Biotech, Inc. (OTC BB: AMZB) today announced that it has a letter of intent from a major medical center to fund the Phase II and Phase III trials for Amazon Biotech, Inc.'s AIDS drug -- AMZ-0026.

Alliances Clinical research Phase I Phase II
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
January 16, 2025
 · 
1 min read
 · 
Lori Ellis
San Francisco, USA - May 20, 2022: historic Cable Car Powell Hyde Line on turntable at Powell Street terminal at Market Street in downtown San Francisco, California CA, USA.
Pipeline
JPM25 Day 3: AbbVie, Gilead, GSK and Dyne
January 16, 2025
 · 
3 min read
 · 
Tristan Manalac
Businessman jump careful on cracked or broken graph. Job opportunity and career. concept of under pressure. risk, financial, and tax
Pipeline
New Safety Signals Force Keros to Fully Terminate Mid-Stage PAH Study
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac